Medtronic estimates that about 10% of Parkinson's patients who could benefit from deep brain stimulation have used it. "Parkinson's Therapy Gets Fresh Look From Device Makers" at 7 a.m. ET, misstated the percentage.

(END) Dow Jones Newswires

January 08, 2017 14:58 ET (19:58 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Medtronic Charts.